Wave Life Sciences (WVE) Cash from Investing Activities Growth (1y) (2015 - 2026)
Wave Life Sciences (WVE) Cash from Investing Activities Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 62.68% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -674.01% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -166.24% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Wave Life Sciences | 1.19 Bn | 649.41 Mn | - | -165.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -165.45% |
| Dec 31, 2025 | 101.16% |
| Sep 30, 2025 | 35.25% |
| Jun 30, 2025 | -488.46% |
| Mar 31, 2025 | 60.43% |
| Dec 31, 2024 | 75.84% |
| Sep 30, 2024 | -93.43% |
| Jun 30, 2024 | 27.78% |
| Mar 31, 2024 | 14.72% |
| Dec 31, 2023 | -101.43% |
| Sep 30, 2023 | 60.48% |
| Jun 30, 2023 | -100.29% |
| Mar 31, 2023 | 99.03% |
| Dec 31, 2022 | 165,700.00% |
| Sep 30, 2022 | -411.22% |
| Jun 30, 2022 | 7,360.77% |
| Mar 31, 2022 | -46,388.89% |
| Dec 31, 2021 | 97.31% |
| Sep 30, 2021 | -50.77% |
| Jun 30, 2021 | -149.26% |